News
Launch of Brilinta® (Ticagrelor) Tablets
Generic Brilinta® (Ticagrelor) has been approved by the FDA. Ticagrelor tablets are indicated to reduce…
Carlisle Medical Will Be Exhibiting At The 2025 SBWC Annual Educational Conference
Carlisle Medical is excited to announce that we will be exhibiting at the 2025 State…
Launch of Generic Xarelto (Rivaroxaban) Tablets
Generic Xarelto (Rivaroxaban) has recently been approved by the FDA and released in 2.5 mg…
Carlisle Medical Will Be Exhibiting At The 2025 Tennessee Workers’ Compensation Educational Conference Copy
Carlisle Medical will be exhibiting at the 2025 Tennessee Workers’ Compensation Educational Conference on June…
Carlisle Medical Will Be Exhibiting At The 2025 Tennessee Workers’ Compensation Educational Conference
Carlisle Medical will be exhibiting at the 2025 Tennessee Workers’ Compensation Educational Conference on June…
Carlisle Medical Will Be Exhibiting At The 2025 Mississippi Workers’ Compensation Educational Association
Carlisle Medical will be exhibiting at the 2025 Mississippi Workers’ Compensation Educational Association on April…
Launch of generic Motegrity (Prucalopride) tablets
Generic Motegrity (Prucalopride) has recently been released and is approved by the FDA. Prucalopride…
Anticipated Generic Releases 2025
There are several brand name medications that will lose exclusivity in the first half of…
LSU Health New Orleans Announces Non-additive, Non-Toxic Painkiller
LSU Health New Orleans announces the discovery and clinical development of a new non-opioid therapeutic…
FDA approves First Nasal Spray for Treatment of Anaphylaxis (neffy) epinephrine nasal spray
Neffy (epinephrine 2 mg/dose) is a nasal spray which may be given to treat a…
